TopPodcast.com
Menu
  • Home
  • Top Charts
  • Top Networks
  • Top Apps
  • Top Independents
  • Top Podfluencers
  • Top Picks
    • Top Business Podcasts
    • Top True Crime Podcasts
    • Top Finance Podcasts
    • Top Comedy Podcasts
    • Top Music Podcasts
    • Top Womens Podcasts
    • Top Kids Podcasts
    • Top Sports Podcasts
    • Top News Podcasts
    • Top Tech Podcasts
    • Top Crypto Podcasts
    • Top Entrepreneurial Podcasts
    • Top Fantasy Sports Podcasts
    • Top Political Podcasts
    • Top Science Podcasts
    • Top Self Help Podcasts
    • Top Sports Betting Podcasts
    • Top Stocks Podcasts
  • Podcast News
  • About Us
  • Podcast Advertising
  • Contact
Not in our directory?
Add Show Here
Podcast Equipment
Center

toppodcastlogoOur TOPPODCAST Picks

  • Comedy
  • Crypto
  • Sports
  • News
  • Politics
  • True Crime
  • Business
  • Finance

Follow Us

toppodcastlogoStay Connected

    View Top 200 Chart
    Back to Rankings Page
    Health & Fitness

    JAMA Oncology Author Interviews

    Interviews with authors of articles from JAMA Oncology. JAMA Oncology is the definitive journal for scientists, clinicians, and trainees in the field of oncology worldwide. Our original, innovative, and timely scientific and educational content provides a deeper understanding of cancer pathogenesis and recent treatment advances for our readers. JAMA Oncology aims to effectively convey the findings of important clinical research, major scientific breakthroughs, actionable discoveries, and state-of-the-art treatment pathways to the oncology community. Our goal is that successful communication of new knowledge will ultimately translate to clinical benefit for people living with and surviving cancer.

    Advertise
    • Apple Podcasts
    • Google Play
    • Spotify
    Latest Episodes:
    Adoption of Innovative Therapies Across Oncology Practices Jan 05, 2023
    Show notes

    Interview with Nancy L. Keating, MD, MPH, author of Adoption of Innovative Therapies Across Oncology Practices—Evidence From Immunotherapy. Hosted by Jack West, MD. Related Content:

    • Adoption of Innovative Therapies Across Oncology Practices—Evidence From Immunotherapy
    Adjuvant Chemotherapy in Patients With Pancreatic Adenocarcinoma After Multiagent Neoadjuvant Chemotherapy Dec 08, 2022
    Show notes

    Interview with Marco Del Chiaro, MD, PhD, author of Association of Adjuvant Chemotherapy in Patients With Resected Pancreatic Adenocarcinoma After Multiagent Neoadjuvant Chemotherapy. Hosted by Jack West, MD. Related Content:

    • Association of Adjuvant Chemotherapy in Patients With Resected Pancreatic Adenocarcinoma After Multiagent Neoadjuvant Chemotherapy
    Association of DCVax-L With Extension of Survival Among Patients With Glioblastoma Nov 17, 2022
    Show notes

    Interview with Linda M. Liau, MD, PhD, author of Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma: A Phase 3 Prospective Externally Controlled Cohort Trial. Hosted by Jack West, MD. Related Content:

    • Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma
    Association of Immune-Related Adverse Event Management With Survival in Patients With Advanced Melanoma Oct 27, 2022
    Show notes

    Interview with Olivier J. van Not, MD, and Karijn P. M. Suijkerbuijk, MD, PhD, authors of Association of Immune-Related Adverse Event Management With Survival in Patients With Advanced Melanoma. Hosted by Jack West, MD. Related Content:

    • Association of Immune-Related Adverse Event Management With Survival in Patients With Advanced Melanoma
    Prostate-Specific Antigen Screening Rates and Metastatic Prostate Cancer Incidence in the VHA Oct 24, 2022
    Show notes

    Interview with Brent S. Rose, MD, author of Association of Prostate-Specific Antigen Screening Rates With Subsequent Metastatic Prostate Cancer Incidence at US Veterans Health Administration Facilities. Hosted by Jack West, MD. Related Content:

    • Association of Prostate-Specific Antigen Screening Rates With Subsequent Metastatic Prostate Cancer Incidence at US Veterans Health Administration Facilities
    Therapy and Survival Patterns in Patients With Stage 2/3 Rectal Cancer Treated With Trimodality Therapy Aug 18, 2022
    Show notes

    Interview with Hagen F. Kennecke, MD, author of Patterns of Practice and Improvements in Survival Among Patients With Stage 2/3 Rectal Cancer Treated With Trimodality Therapy. Hosted by Jack West, MD.

    Global Association of COVID-19 Pandemic Measures With Cancer Screening Jul 07, 2022
    Show notes

    Interview with Paolo Boffetta, MD, author of Global Association of COVID-19 Pandemic Measures With Cancer Screening: A Systematic Review and Meta-analysis. Hosted by Jack West, MD.

    A Conversation With Dr Kirsten Bibbins-Domingo, JAMA's New Editor in Chief Jul 05, 2022
    Show notes

    In July 2022, Kirsten Bibbins-Domingo, PhD, MD, MAS, took on a new role as the 17th editor in chief of JAMA and the JAMA Network. In conversation with Nobel laureate Harold Varmus, MD, Bibbins-Domingo discusses her research background, approaches to leadership in health care, and the critical role that journals play in communication about public health and science. Related Content:

    • The Urgency of Now and the Responsibility to Do More—My Commitment for JAMA and the JAMA Network
    • A Conversation With Dr Kirsten Bibbins-Domingo, JAMA's New Editor in Chief (video)
    • A Conversation With Dr Kirsten Bibbins-Domingo, JAMA's New Editor in Chief (audio)
    High TMB in NSCLC and Increased Immune Infiltration and Improved Clinical Outcomes of PD-L1 Blockade Jun 16, 2022
    Show notes

    Interview with Mark M. Awad, MD, PhD, author of Association of High Tumor Mutation Burden in Non–Small Cell Lung Cancers With Increased Immune Infiltration and Improved Clinical Outcomes of PD-L1 Blockade Across PD-L1 Expression Levels. Hosted by Jack West, MD.

    Association of 5α-Reductase Inhibitors With Prostate Cancer Mortality May 19, 2022
    Show notes

    Interview with Lars Björnebo, MSc, and Anna Lantz, MD, PhD, authors of Association of 5α-Reductase Inhibitors With Prostate Cancer Mortality. Hosted by Jack West, MD.

    Previous 1 2 3 4 5 6 13 Next

    Related Podcasts

    Fresh Air

    1

    Fresh Air Arts
    Twenty Thousand Hertz

    2

    Twenty Thousand Hertz Arts
    The Black Tapes

    3

    The Black Tapes Arts
    Snap Judgment

    4

    Snap Judgment Arts
    Here’s The Thing with Alec Baldwin

    5

    Here’s The Thing with Alec Baldwin Arts
    The NoSleep Podcast – Creative Reason Media Inc.

    6

    The NoSleep Podcast – Creative Reason Media Inc. Arts
    footer-logo

    Contact Us

    Toll Free: 844-670-7747

    Links

    • Home
    • Top Charts
    • Networks
    • Apps
    • Independents Podcasts
    • Podcast Advertising
    • Podcast News
    • Contact Us
    • About Us
    • Analytics & Insights

    Stay Connected

      Privacy, Terms of Use & Our Code of Ethics Protecting Content Creators Copyrights